Recommendations for use of ezetimibe and/or PCSK9 inhibitors in patients with elevated LDL-C

Authors: Michelle D. Kelsey, L. Kristin Newby

Published: 2022-08-01

DOI: 10.7326/j22-0060

Source: Full article

Abstract

No abstract found.